On the other hand, GSTO1 knockout (Fig. 3J) and treatment with a GSTO1 inhibitor (Fig. 3K) sensitized bladder cancer cells to cisplatin cytotoxicity. This evidence concerns the gene GSTO1 and urinary bladder carcinoma.